Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,911 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV

NCT05551273

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +18 more
Locations
  • UCSD Antiviral Research Center CRS (Site 701) San Diego, California, United States
  • The Ponce de Leon Center CRS (Site 5802) Atlanta, Georgia, United States
  • Weill Cornell Chelsea CRS (Site 7804) New York, United States
  • Greensboro CRS (Site# 3203) Greensboro, North Carolina, United States
View Trial Details
Completed

Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)

NCT05099965

Conditions
Blood-Borne Infections, Communicable Diseases, Cytomegalovirus Infections, +15 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • UCSD Antiviral Research Center San Diego, California, United States
  • Ucsf Hiv/Aids Crs San Francisco, California, United States
View Trial Details
Completed

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

NCT03304639

Conditions
Adenocarcinoma, Advanced Merkel Cell Carcinoma, Carcinoma, +21 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 254 locations
View Trial Details
Completed

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

NCT02362035

Conditions
Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details

Related conditions